Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factor
B. Linderholm, J. Bergqvist, H. Hellborg, U. Johansson, M. Linderholm, E. von Schoultz, G. Elmberger, L. Skoog, J. BerghVolume:
26
Language:
english
Pages:
11
DOI:
10.1007/s12032-008-9157-9
Date:
December, 2009
File:
PDF, 455 KB
english, 2009